Talk to someone specialized in headache

Headache treatments are rapidly evolving. You deserve a care team that understands your symptoms and is up-to-date on the latest evidence-based approaches to headache and migraine management.

Meet our clinical leadership

Nada Hindiyeh, MD

Dr. Hindiyeh is a UCNS-certified headache specialist and former Associate Professor of Neurology at Stanford University, where she treated patients, led over 25 clinical trials as the Director of Headache Clinical Research and instructed headache fellows and neurology residents.

Susan Hutchinson, MD

Dr. Hutchinson is a UCNS-certified headache specialist and the founder of the Orange County Migraine & Headache Center in Irvine, California. The driving passion in her life is to alleviate the suffering from migraine in patients’ lives and to help give them their lives back.

Andrew Blumenfeld, MD

Dr. Blumenfeld is a UCNS-certified headache specialist, board-certified neurologist, and is one of the developers of the Botox for migraine protocol. He is also an avid researcher and holds 27 patents related to headache treatment.

Kenneth P. Martinez, MD

Dr. Martinez is a UCNS-certified headache specialist, board-certified neurologist, and the founder of the Neurology and Pain Specialty Center in Aliso Viejo, California. He has spent more than 20 years in private practice, specializing in diagnosing and treating neurological diseases with a specific interest in headache disorders.

In-network care with major PPO plans in CA

Evidence behind Haven’s model

Calcitonin gene-related peptide-targeting therapies are a first-line option for the prevention of migraine: An American Headache Society position statement update

March 11, 2024
Andrew C. Charles MD, Kathleen B. Digre MD, Peter J. Goadsby MD, PhD, Matthew S. Robbins MD, Andrew Hershey MD, PhD, The American Headache Society

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study

January 25, 2022
Richard B. Lipton MD, Robert A. Nicholson PhD, Michael L. Reed PhD, Andre B. Araujo PhD, Dena H. Jaffe PhD, Douglas E. Faries PhD, Dawn C. Buse PhD, Robert E. Shapiro MD, PhD, Sait Ashina MD, M. Janelle Cambron-Mellott PhD, John C. Rowland MS, Eric M. Pearlman MD, PhD

The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

June 23, 2021
Jessica Ailani MD, Rebecca C. Burch MD, Matthew S. Robbins MD, on behalf of the Board of Directors of the American Headache Society

Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study

April 1, 2021
Dawn C. Buse PhD, Cynthia E. Armand MD, Larry Charleston IV MD, MSc, Michael L. Reed PhD, Kristina M. Fanning PhD, Aubrey Manack Adams PhD, Richard B. Lipton MD

Botulinum Toxin in the Treatment of Headache

December 17, 2020
Werner J. Becker

Migraine is first cause of disability in under 50s: will health politicians now take notice?

February 21, 2018
Timothy J. Steiner, Lars J. Stovner, Theo Vos, R. Jensen, Z. Katsarava

We’re here to help you manage your headaches and have more good days.